Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors
Clinical trial NCT03552406 · UNKNOWN
Trial details
- NCT number
- NCT03552406
- Sponsor
- ISU Abxis Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-27
- Primary completion
- 2020-10-19
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.